JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4495 NCH 51

Summary: Histone deacetylase (HDAC) inhibitor
A4510 1,2,3,4,5,6-Hexabromocyclohexane

Summary: JAK2 tyrosine kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
A8255 Sunitinib malate
5 Citation

Target: VEGFR

Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor

≥26.65 mg/mL
A8322 Neratinib (HKI-272)
3 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A8354 A66

Target: PI3K

Summary: P110α inhibitor

insoluble in H2O; ≥19.7 mg/mL
A8376 Bephenium Hydroxynaphthoate

Summary: Anthelmintic agent

insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
A8639 Deferasirox
3 Citation

Summary: Oral iron chelator

insoluble in H2O; ≥37.28 mg/mL
A8647 Capecitabine

Summary: DNA, RNA and protein synthesis inhibitor

≥10.97 mg/mL
B1164 MK-4827 tosylate

Summary: PARP1/PARP2 inhibitor

≥51.4 mg/mL
B1394 Tamoxifen Citrate

Target: Estrogen and Related Receptors

Summary: Antiestrogen drug

≥28.2 mg/mL